| Bristol-Myers Squibb Company (BMY) | |||
|---|---|---|---|
| 50.13 -1.17 (-2.28%) | 02-21 16:00 | ||
| Open: | 51.08 | Pre. Close: | 51.3 |
| High: | 52.8 | Low: | 50.09 |
| Volume: | 25,946,991 | Market Cap: | 81835M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 52.848 - 53.279 | 53.279 - 53.568 |
| Low: | 49.31 - 49.773 | 49.773 - 50.083 |
| Close: | 49.55 - 50.26 | 50.26 - 50.737 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 59.47 One year: 61.66 |
| Support: | Support1: 47.88 Support2: 39.84 |
| Resistance: | Resistance1: 50.91 Resistance2: 52.79 |
| Pivot: | 50.52  |
| Moving Averages: | MA(5): 51.06 MA(20): 50.06 MA(100): 52.40 MA(250): 55.83 |
| MACD: | MACD(12,26): 0.34 Signal(12,26,9): 0.23 |
| %K %D: | %K(14,3): 67.53 %D(3): 80.75 |
| RSI: | RSI(14): 49.44 |
| 52-Week: | High: 68.88 Low: 44.3 Change(%): -23.9 |
| Average Vol(K): | 3-Month: 1498349 10-Days: 1450192 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.BMY has closed above bottom band by 36.1%. Bollinger Bands are 55.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
2019-02-21T16:30:00-05:00 According To Sources Bristol-Myers/Celgene: 6 Factors Driving The Deal Spread (Podcast) 2019-02-21T07:14:05-05:00 U.S. healthcare spending to rise 5.5% per annum over next decade |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability | |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Major | |
| Shares Out. (M) | 1632.46 |
| Shares Float (M) | 1626.36 |
| % Held by Insiders | |
| % Held by Institutions | 105.60 |
| Shares Short (K) | 57527 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 3.980 |
| EPS Est. Current Year | 3.000 |
| EPS Est. Next Year | 3.230 |
| EPS Est. Next Quarter | 0.790 |
| Forward EPS | 3.720 |
| Book Value (p.s.) | 5.950 |
| PEG Ratio | 1.25 |
| Profit Margin | 23.07 |
| Operating Margin | 28.99 |
| Return on Assets (ttm) | 22.4 |
| Return on Equity (ttm) | 42.2 |
| Qtrly Rev. Growth | 9.6 |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | |
| Stock Valuation | |
|---|---|
| P/E | 12.60 |
| P/E Growth Ratio | -0.02 |
| P/BV | 8.43 |
| P/S | 5914942464.00 |
| P/CF | |
| Dividend Yield | 0.06 |
| Dividends & Splits | |
|---|---|
| Dividend | 3.174 |
| Dividend Pay Date | 2019-02-01 |
| Ex-Dividend Date | 2019-01-03 |
| Forward Dividend | 1.640 |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
